Exane Derivatives Livent Corp. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Livent Corp. stock. As of the latest transaction made, Exane Derivatives holds 98 shares of LTHM stock, worth $485. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98
Previous 98
-0.0%
Holding current value
$485
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LTHM
# of Institutions
36Shares Held
2.2MCall Options Held
0Put Options Held
0-
Met Life Investment Management, LLC Whippany, NJ1.24MShares$6.14 Million0.03% of portfolio
-
Agf Investments Inc. Toronto, A6325KShares$1.61 Million0.09% of portfolio
-
Pfs Investments Inc. Duluth, GA115KShares$569,2450.05% of portfolio
-
Eaton Vance Management Boston, MA98.1KShares$485,5900.0% of portfolio
-
Regent Investment Management LLC58KShares$287,2230.31% of portfolio
About Livent Corp.
- Ticker LTHM
- Exchange NYSE
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 179,270,000
- Market Cap $887M
- Description
- Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performa...